These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 177281)

  • 41. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
    Wilks CR
    Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis of equid herpesviruses -1 and -4 by polymerase chain reaction.
    Sharma PC; Cullinane AA; Onions DE; Nicolson L
    Equine Vet J; 1992 Jan; 24(1):20-5. PubMed ID: 1313360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and sero-epizootiology of equine herpesvirus type 1 and type 4 infections in Japan using a type-specific ELISA.
    Yasunaga S; Maeda K; Matsumura T; Kai K; Iwata H; Inoue T
    J Vet Med Sci; 1998 Oct; 60(10):1133-7. PubMed ID: 9819768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation.
    Gibson JS; Slater JD; Awan AR; Field HJ
    Arch Virol; 1992; 123(3-4):351-66. PubMed ID: 1314051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Demonstration of equine herpes virus 1 (EHV-1) in histological sections and tissue cultures by the peroxidase-antiperoxidase (PAP) technique.
    Gimeno EJ; Nosetto EO; Martin AA; Galosi CM; Ando Y; Etcheverrigaray ME
    Zentralbl Veterinarmed B; 1987 Dec; 34(10):740-2. PubMed ID: 2830744
    [No Abstract]   [Full Text] [Related]  

  • 48. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse.
    Stokes A; Wardley RC
    Res Vet Sci; 1988 May; 44(3):295-302. PubMed ID: 2841731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphocytes from ponies experimentally infected with equine herpesvirus 1: subpopulation dynamics and their response to mitogens.
    Bumgardner MK; Dutta SK; Campbell DL; Myrup AC
    Am J Vet Res; 1982 Jul; 43(7):1308-10. PubMed ID: 6285778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relevance of infection with equine herpesvirus 1 (EHV-1) in a German thoroughbred stud: vaccination, abortion and diagnosis].
    Schröer U; Lange A; Glatzel P; Ludwig H; Borchers K
    Berl Munch Tierarztl Wochenschr; 2000 Feb; 113(2):53-9. PubMed ID: 10726362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response.
    Wilks CR; Coggins L
    Am J Vet Res; 1976 May; 37(5):486-92. PubMed ID: 179451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of equine herpesvirus 1 recombinant glycoprotein D and development of an agar gel immunodiffusion test for serological diagnosis.
    Fuentealba N; Sguazza G; Scrochi M; Bravi M; Zanuzzi C; Corva S; Gimeno E; Pecoraro M; Galosi C
    J Virol Methods; 2014 Jun; 202():15-8. PubMed ID: 24631347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Equine herpesvirus 1: biological and biophysical comparison of two viruses from different clinical entities.
    Borgen HC; Ludwig H
    Intervirology; 1974; 4(3):189-98. PubMed ID: 4376548
    [No Abstract]   [Full Text] [Related]  

  • 57. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.
    Bell SA; Balasuriya UB; Gardner IA; Barry PA; Wilson WD; Ferraro GL; MacLachlan NJ
    Vet Microbiol; 2006 Sep; 116(4):249-57. PubMed ID: 16774810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
    Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T
    J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skin hypersensitivity to equid herpesvirus type 1 in horses.
    Frymus T; Woyciechowska S; Schollenberger A; Poliwoda A
    Zentralbl Veterinarmed B; 1978 Jun; 25(5):431-4. PubMed ID: 211756
    [No Abstract]   [Full Text] [Related]  

  • 60. Vaccines for equine herpesvirus type 1.
    Studdert MJ
    Vet Rec; 1983 Apr; 112(14):334. PubMed ID: 6304985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.